Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Integrated Proteins Ltd. Capital/Financing Update 2024

Nov 27, 2024

63180_rns_2024-11-27_992a2ef8-7e5a-4a35-9f7e-71d85b16fd6c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [86 x 130] intentionally omitted <==

INTEGRATED PROTEINS LIMITED

City Point, 5[th] Floor, Opp. Town Hall, Jamnagar – 361 001,Gujarat,India Phone: (0288) 2551901 Fax: (0288) 2552566 Email ID:[email protected] Website: www.integratedproteins.com CIN: L15400GJ1992PLC018426

27[th] November, 2024

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400001

Scrip Code: 519606

Sub: Regulation 30(6) read with Schedule III, Part A, Para A of the SEBI Listing Regulations regarding Preferential Allotment

Dear Sir/Madam,

With reference to above subject and in compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Director at its meeting held on today i.e., Wednesday, 27[th] November 2024, inter alia considered and approved the following:

  1. Issuance and allotment of upto 2,00,00,000 (Two Crores) Convertible Equity Warrants (hereinafter referred to as "Warrants") in one or more tranches on preferential basis (“Preferential Offer”) to non-promoter entity / public category as mentioned below ("Warrant Holder"/” Proposed Allottee”) for cash consideration at a price of Rs. 11.25/-, as arrived in accordance with the regulation 165 of ICDR Regulations (including the warrant subscription price and the warrant exercise price) aggregating upto Rs. 22,50,00,000/- (Rupees Twenty-Two Crores Fifty Lakh Only) with reference to the Relevant Date i.e. Friday, November 29, 2024 (Since, the relevant date for preferential issue in accordance with regulation 161 is arrived on Saturday November 30, 2024 which is weekend therefore preceding day i.e. Friday, November 29, 2024 is considered as relevant date.)

  2. The Detailed disclosure as required under Regulation 30(6) read with Schedule III, Part A, Para A of the SEBI Listing Regulations and the SEBI Circular CIR/CFDlCMDl4l2015 dated 9 September 2015 for preferential issue is attached herewith as an Annexure- A

Kindly take the same on your records.

Thanking you,

Yours faithfully,

For Integrated Proteins Limited

DEVANSHI Digitally signed by DEVANSHI VIJAYBHAI SHAH VIJAYBHAI SHAH Date: 2024.11.27 21:44:27 +05'30'

CS Devanshi V. Shah Company Secretary Membership No.: A50711

==> picture [86 x 130] intentionally omitted <==

INTEGRATED PROTEINS LIMITED City Point, 5[th] Floor, Opp. Town Hall, Jamnagar – 361 001,Gujarat,India Phone: (0288) 2551901 Fax: (0288) 2552566 Email ID:[email protected] Website: www.integratedproteins.com CIN: L15400GJ1992PLC018426

ANNEXURE-A

Disclosure with respect to the preferential issue as required under Regulation 30(6) read with Schedule III, Part A, Para A of the SEBI Listing Regulations and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015

SN Particulars Details Details Details Details
1 Types of Securities
proposed to be issued
Convertible equity warrants carrying a right to subscribe 1 (one)
Equity Share per warrant.
2 Types of Issuances Preferential allotment on a private placement basis in accordance
with the provisions of the Companies Act, 2013 and the rules made
thereunder
and
SEBI
(Issue
of
Capital
and
Disclosure
Requirements)
Regulations,
2018,
as
amended
("ICDR
Regulations") and other applicable laws
3 Total number of securities
proposed to be issued or
the total amount for which
the securities will be issued
(Approximately)
2,00,00,000 (Two Crores) Convertible Equity Warrants (hereinafter
referred to as "Warrants") on preferential basis (“Preferential Offer”)
to the non-promoter entity in public category as mentioned below
("Warrant Holder"/” Proposed Allottee”) for cash consideration at a
price of Rs. 11.25/-, aggregating upto Rs. 22,50,00,000/- (Rupees
Twenty-Two Crores Fifty Lakh Only).
The price of the warrants has been determined in accordance with
the ICDR Regulations. The preferential issue will be undertaken for
cash consideration.
An amount equivalent to 25% of the Warrant Issue Price shall be
payable at the time of subscription and allotment of each Warrant
and the balance 75% shall be payable by the Warrant holder(s) on
the exercise of Warrant(s).
The price of the warrants and the number of Equity Shares to be
allotted on conversion of warrants shall be subject to appropriate
adjustments as permitted under applicable laws.
4 Name of the Investors Sr No. Name of Allottees No. of
shares
1 Chetna Mithani 10,00,000
2 Vedankit Traders Private Limited 10,00,000
3 Hiya Chotalia 10,00,000

==> picture [86 x 130] intentionally omitted <==

INTEGRATED PROTEINS LIMITED City Point, 5[th] Floor, Opp. Town Hall, Jamnagar – 361 001,Gujarat,India Phone: (0288) 2551901 Fax: (0288) 2552566 Email ID:[email protected] Website: www.integratedproteins.com CIN: L15400GJ1992PLC018426

SN Particulars Details
4 Prakash Desai 10,00,000
5 Vikas Gupta 2,50,000
6 Nishant Dublish 2,50,000
7 Gemzar Enterprises Pvt Ltd 10,00,000
8 Dalmia Industrial Development
Limited
10,00,000
9 Karanj Doshi 2,50,000
10 Shashank Doshi 11,00,000
11 Hetal Doshi 11,00,000
12 Tej Doshi 11,00,000
13 Kavya Doshi 11,00,000
14 Hinaben Dhruve 2,50,000
15 Vastal Pandya 2,50,000
16 Varsha Rajni Mungra 10,00,000
17 Leenaguri Divyang Vadi 10,00,000
18 Divyang Vadi 10,00,000
19 Rajni Mungra 10,00,000
20 Ashish Shah 10,00,000
21 Wealth mine Networks Private
Limited
11,40,000
22 Sappers Infra Realtors Private
Limited
11,10,000
23 Morning Vinimay Private Limited 11,00,000
Total 2,00,00,000
5 Post allotment of
securities- outcome of the
subscription
The convertible equity warrants are proposed to be allotted to non-
promoter entity/investor. Details of the shareholding of Investors in
the Company, prior to and after the proposed Preferential Issue, are
as under:

==> picture [86 x 130] intentionally omitted <==

INTEGRATED PROTEINS LIMITED

City Point, 5[th] Floor, Opp. Town Hall, Jamnagar – 361 001,Gujarat,India Phone: (0288) 2551901 Fax: (0288) 2552566 Email ID:[email protected] Website: www.integratedproteins.com CIN: L15400GJ1992PLC018426

SN Particulars Details
Name of
Allottees
Pre issue
Shareholding
Post issue*
shareholding**
No. of
shares
% of
shareholding
No. of
Shares
% of
sharehold
ing
Chetna
Mithani
0 0 10,00,000 4.31
Vedankit
Traders
Private
Limited
0 0 10,00,000 4.31
Hiya Chotalia 0 0 10,00,000 4.31
Prakash
Desai
0 0 10,00,000 4.31
Vikas Gupta 0 0 2,50,000 1.08
Nishant
Dublish
0 0 2,50,000 1.08
Gemzar
Enterprises
Pvt Ltd
0 0 10,00,000 4.31
Dalmia
Industrial
Development
Limited
0 0 10,00,000 4.31
KaranjDoshi 0 0 2,50,000 1.08
Shashank
Doshi
0 0 11,00,000 4.74
Hetal Doshi 0 0 11,00,000 4.74
TejDoshi 0 0 11,00,000 4.74
Kavya Doshi 0 0 11,00,000 4.74
Hinaben
Dhruve
0 0 2,50,000 1.08
Vastal
Pandya
0 0 2,50,000 1.08
Varsha Rajni
Mungra
0 0 10,00,000 4.31
Leenaguri
Divyang Vadi
0 0 10,00,000 4.31
DivyangVadi 0 0 10,00,000 4.31
Rajni Mungra 0 0 10,00,000 4.31
Ashish Shah 0 0 10,00,000 4.31
Wealth Mine
Networks
Private
Limited
0 0 11,40,000 4.91

==> picture [86 x 130] intentionally omitted <==

INTEGRATED PROTEINS LIMITED

City Point, 5[th] Floor, Opp. Town Hall, Jamnagar – 361 001,Gujarat,India Phone: (0288) 2551901 Fax: (0288) 2552566 Email ID:[email protected] Website: www.integratedproteins.com CIN: L15400GJ1992PLC018426

SN Particulars Details
Sappers Infra
Realtors
Private
Limited
0 0 11,10,000 4.78
Morning
Vinimay
Private
Limited
0 0 11,00,000 4.74
Total 0 0
2,00,00,000
6 Issue Price Rs. 11.25/- (Rupees Eleven point Twenty-Five
convertible equity warrants as per ICDR Regulation
Only) per
7 Number of Investor 23(Twenty-three)
8 In case of convertibles —
intimation on conversion
of securities or on lapse of
the tenure of the
instrument;
The tenure of the warrants shall not exceed 18 (eighteen) months
from the date of allotment. Each warrant shall carry a right to
subscribe 1 (one) Equity Share per warrant, which may be exercised
in one or more tranches during the period commencing from the date
of allotment of warrants until the expiry of 18 (eighteen) months from
the date of allotment of the warrants.
In the event that, a warrant holder does not exercise the warrants
within a period of 18 (Eighteen) months from the date of allotment of
such warrants, the unexercised warrants shall lapse and the amount
paid by the warrant holders on such Warrants shall stand forfeited
by the Company.
9 Any cancellation or
termination of proposal
for issuance of securities
includingreasons thereof.
Not Applicable